ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
44 announcements with these filters
Dr. Agarwal's Health Care Ltd held a creditor meeting for its amalgamation with Dr. Agarwal's Eye Hospital. The meeting, convened by NCLT, considered the scheme under Companies Act provisions.
Dr. Agarwal's Health Care Ltd held an NCLT-convened shareholder meeting to approve its amalgamation with Dr. Agarwal's Eye Hospital Ltd. The meeting was convened to pass a special majority resolution under the Companies Act.
CRISIL reaffirmed and withdrew its AA- rating on Dr. Agarwal's debt facilities. The withdrawal follows a company request with lender consent; ICRA continues to rate the facilities.
Dr. Agarwal's Health Care Limited convened an NCLT-ordered shareholder meeting for July 02, 2026, to approve its amalgamation with Dr. Agarwal's Eye Hospital Limited. The merger aims to consolidate eye care operations and improve capital efficiency.
Dr. Agarwal's Health Care completed incorporating a new wholly owned subsidiary in Ethiopia. The ₹2,000,000 Crore transaction marks the firm's strategic entry into the Ethiopian market.
Dr. Agarwal’s reported strong FY26 performance, crossing INR 2,000cr revenue milestone with significant network expansion and EBITDA margin improvement to 28.9%.
Dr. Agarwal’s Health Care incorporated Orbit Health Care ETH PLC in Ethiopia via a ₹1.90 Crore investment. The new entity becomes an indirect wholly owned subsidiary.
Dr. Agarwal's Health Care Limited allotted 25,240 equity shares under its ESOP scheme. The issuance marginally increases the company's total paid-up share capital.
Dr. Agarwal's Health Care allotted 25,240 shares under its ESOP scheme, valued at ₹0.33 Crore. The allotment increases the company's total paid-up equity share capital.
Dr. Agarwals reported 21% income growth in FY26, driven by aggressive network expansion (57 new facilities) and clinical excellence.
Dr. Agarwals Health Care Ltd reported revenue from operations of ₹564.1 Cr (+22.6% YoY) and net profit of ₹50 Cr (+17.6% YoY) for Q4 FY26.
Dr. Agarwal’s Health Care reported FY2026 total income of ₹2125.00 Crore, a 20.9% year-on-year growth. Net profit surged 52.4% to ₹168 Crore alongside significant network expansion.
Dr. Agarwals Health Care received a ₹20.50 Crore GST show cause notice for FY 2023-24. The company is evaluating legal steps to respond within thirty days.
Dr. Agarwal’s Health Care scheduled a board meeting for May 21, 2026, to approve annual financial results. An earnings call will follow the meeting same day.